127 related articles for article (PubMed ID: 1555693)
1. Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program.
Acharya U; Small J; Randall J; Hamilton M; Templeton A
Fertil Steril; 1992 Apr; 57(4):815-8. PubMed ID: 1555693
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program.
Acharya U; Irvine S; Hamilton M; Templeton A
Fertil Steril; 1992 Dec; 58(6):1169-73. PubMed ID: 1459268
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
Olivennes F; Belaisch-Allart J; Emperaire JC; Dechaud H; Alvarez S; Moreau L; Nicollet B; Zorn JR; Bouchard P; Frydman R
Fertil Steril; 2000 Feb; 73(2):314-20. PubMed ID: 10685535
[TBL] [Abstract][Full Text] [Related]
4. The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study.
Kingsland C; Tan SL; Bickerton N; Mason B; Campbell S
Fertil Steril; 1992 Apr; 57(4):804-9. PubMed ID: 1555691
[TBL] [Abstract][Full Text] [Related]
5. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
[TBL] [Abstract][Full Text] [Related]
6. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.
Tan SL; Kingsland C; Campbell S; Mills C; Bradfield J; Alexander N; Yovich J; Jacobs HS
Fertil Steril; 1992 Apr; 57(4):810-4. PubMed ID: 1555692
[TBL] [Abstract][Full Text] [Related]
7. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
[TBL] [Abstract][Full Text] [Related]
9. Performance of cryopreserved pre-embryos obtained in in vitro fertilization cycles with or without a gonadotropin-releasing hormone agonist.
Oehninger S; Toner JP; Veeck LL; Brzyski RG; Acosta AA; Muasher SJ
Fertil Steril; 1992 Mar; 57(3):620-5. PubMed ID: 1740208
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization.
Maroulis GB; Emery M; Verkauf BS; Saphier A; Bernhisel M; Yeko TR
Fertil Steril; 1991 Jun; 55(6):1157-64. PubMed ID: 1903732
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization.
Imoedemhe DA; Sigue AB; Pacpaco EL; Olazo AB
Fertil Steril; 1991 Feb; 55(2):328-32. PubMed ID: 1899396
[TBL] [Abstract][Full Text] [Related]
12. Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins.
Caspi E; Ron-El R; Golan A; Nachum H; Herman A; Soffer Y; Weinraub Z
Fertil Steril; 1989 Jan; 51(1):95-9. PubMed ID: 2521328
[TBL] [Abstract][Full Text] [Related]
13. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
15. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial.
Wang Y; Kuang Y; Chen Q; Cai R
Trials; 2018 Aug; 19(1):455. PubMed ID: 30134964
[TBL] [Abstract][Full Text] [Related]
17. Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication.
Itskovitz-Eldor J; Kol S; Mannaerts B
Hum Reprod; 2000 Sep; 15(9):1965-8. PubMed ID: 10966996
[TBL] [Abstract][Full Text] [Related]
18. The use of gonadotropin-releasing hormone analogs for in vitro fertilization: comparison between the standard form and long-acting formulation of D-Trp-6-luteinizing hormone-releasing hormone.
Vauthier D; Lefebvre G
Fertil Steril; 1989 Jan; 51(1):100-4. PubMed ID: 2521322
[TBL] [Abstract][Full Text] [Related]
19. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
20. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
